AllegraLab Article: Liminality, Biomedicine, and the Law – A Symposium Supported by the Wellcome Trust

The Liminal Spaces team discuss their recent symposium on liminality and health research regulation in the United Kingdom with AllegraLab.


Liminality, Biomedicine, and the Law – A Symposium Supported by the Wellcome Trust

Biomedicine and the life sciences continue to rearrange the relationship between culture and biology, problematizing what it means to be a person, and introducing uncertainty and instability to individual and public life. When this occurs, law is often called upon in response. Is this the best option? Why do we always turn to law to deal with ethical tensions or uncertainty in technoscience?

» Read more

Transitional Spaces

Transitional Spaces explore opportunities to accelerate medical advances by anticipating regulatory issues.

The law is notoriously slow to respond to new and emerging advances in medicine, science and technology. The challenges are manifold because different areas of biomedicine develop at different rates, and different countries are affected in their regulatory responses by varying economic, cultural and moral considerations.

This space will address the following research questions:

  • What does legal foresighting contribute to bringing about effective transitions in the biomedical sciences?
  • What conditions are required to ensure the interoperability of effective regulatory approaches between different sectors of scientific enquiry, improving regulatory efficiency for emerging biomedical research?